Shende Medical Closes $27.2M Series D Financing for MRI-PHIFU Systems

Shanghai-based Shende Medical has closed RMB 200 million ($27.2 million) Series D financing for R&D, clinical trials, registration, and commercialization of MRI-Magnetic Resonance Imaging- Phased High-Intensity Focused Ultrasound (MRI-PHIFU) systems with a focus on neurology, prostate, and medical aesthetics products, as well as the establishment of subsidiaries in Europe and the United States.

Based on nearly 40 years of important scientific research by the team of academician Yazhu Chen of Shanghai Jiaotong University, Shende Medical has grown rapidly, raising four consecutive rounds of funding in the past three years, with a cumulative total of nearly RMB 400 million ($54.4 million).

en_GBEnglish (UK)